Lipomatosis, not elsewhere classified, drug-induced

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat.

Hospital discharge: ATC codes for adverse effects of drugs ANY
Hospital Discharge: ICD-10 E88.2#

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector E4_LIPOMATOSIS_ADVERSE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF5
Parent code in ICD-10 E88
Name in latin Lipomatosis non alibi classificata

Similar endpoints

List of similar endpoints to Lipomatosis, not elsewhere classified, drug-induced based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: E4_LIPOMATOSIS_ADVERSE – Lipomatosis, not elsewhere classified, drug-induced
GWS hits:

Survival analyses between endpoints

Plot

before Lipomatosis, not elsewhere classified, drug-induced
after Lipomatosis, not elsewhere classified, drug-induced

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Lipomatosis, not elsewhere classified, drug-induced